165 related articles for article (PubMed ID: 2431174)
1. [Spontaneous variability of ventricular arrhythmias and evaluation of antiarrhythmic drug efficacy--studies evaluating the correlation between ventricular ectopic beat frequency and heart rate].
Ito M; Tsumabuki S; Maeda Y; Arita M
Rinsho Byori; 1986 Aug; 34(8):939-48. PubMed ID: 2431174
[No Abstract] [Full Text] [Related]
2. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous variability of premature ventricular complexes and its significance in assessing anti-arrhythmic drug efficacy.
Dai CZ; Zhang YL; Zeng B; Lu YX
Chin Med J (Engl); 1989 Apr; 102(4):273-7. PubMed ID: 2477200
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
Ferrara E; Vitali A; Cucchi GF
Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
[No Abstract] [Full Text] [Related]
5. Spontaneous variability and detection of repetitive extrasystoles during simulated acute antiarrhythmic testing.
Hernández-Acosta K; Groning E; Rodríguez-Bereao C; Hernández-Cañero A; García-Barreto D
Cor Vasa; 1985; 27(4):287-92. PubMed ID: 2414060
[TBL] [Abstract][Full Text] [Related]
6. [Spontaneous variability of ventricular extrasystole in chronic Chagas cardiopathy].
Grupi CJ; Sosa EA; De Carvalho JF; Antonelli RH; Bellotti G; Pileggi F
Arq Bras Cardiol; 1991 Jun; 56(6):445-50. PubMed ID: 1726676
[TBL] [Abstract][Full Text] [Related]
7. [Relation between ventricular premature contraction frequency and heart rate and analysis of antiarrhythmic effects of calcium channel blockers].
Ito M; Maeda Y; Arita M
Rinsho Byori; 1985 Jan; 33(1):33-42. PubMed ID: 2581003
[No Abstract] [Full Text] [Related]
8. [Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
Korsukewitz J; Wegscheider K; Schmutzler H
Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1103-7. PubMed ID: 2408842
[TBL] [Abstract][Full Text] [Related]
9. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
Peralta Heredia R
Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
[TBL] [Abstract][Full Text] [Related]
10. [The significance of spontaneous variability in ventricular extrasystole in the evaluation of the effectiveness of therapy of ventricular extrasystole].
Daxner P; Snincák M; Kepic S; Puskár V; Prokop M
Vnitr Lek; 1990 Sep; 36(9):840-6. PubMed ID: 1701280
[TBL] [Abstract][Full Text] [Related]
11. [Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations].
Mazur NA; Kurbanov RD
Ter Arkh; 1984; 56(9):67-70. PubMed ID: 6083611
[TBL] [Abstract][Full Text] [Related]
12. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
Andresen D; von Leitner ER; Wegscheider K; Schröder R
Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
[No Abstract] [Full Text] [Related]
14. [Antiarrhythmic action of beta-blocking agent in patients with mitral valve prolapse having premature ventricular contractions].
Shioto T; Takenaka K; Sakamoto T; Amano K; Suzuki J; Amano W; Takahashi H; Sugimoto T
J Cardiol Suppl; 1989; 21():65-72, discussion 73-4. PubMed ID: 2476544
[TBL] [Abstract][Full Text] [Related]
15. [Optimization of the use of etmozin in treating patients suffering from frequent ventricular extrasystole].
Bugriĭ EM; Mazur NA; Pavlova TS; Dzhishambaev ED
Ter Arkh; 1986; 58(6):62-5. PubMed ID: 2429379
[TBL] [Abstract][Full Text] [Related]
16. [Spontaneous variability of ventricular extrasystoles: criteria for validating anti-arrhythmia therapy in relation to the length of the control interval].
Schmidt G; Goedel-Meinen L; Ulm K; Jahns G; Barthel P; Stief P; Schaudig UH; Klein G; Baedeker W; Blömer H
Z Kardiol; 1987 May; 76(5):292-5. PubMed ID: 2441534
[TBL] [Abstract][Full Text] [Related]
17. [Spontaneous variability of complex ventricular extrasystoles over a period of up to 4 years].
Schmidt G; Ulm K; Goedel-Meinen L; Barthel P; Jahns G; Stief B; Klein G; Baedeker W; Blömer H
Z Kardiol; 1988 Feb; 77(2):89-92. PubMed ID: 2452524
[TBL] [Abstract][Full Text] [Related]
18. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
Gertsch M
Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
[TBL] [Abstract][Full Text] [Related]
19. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Bluschke V; Breithardt G; Abendroth RR; Seipel L
Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
[TBL] [Abstract][Full Text] [Related]
20. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
Wagner WL; Manz M; Lüderitz B
Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
